We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial.
- Authors
Ratjen, Felix; Munck, Anne; Kho, Pearl; Angyalosi, Gerhild; ELITE Study Group
- Abstract
Antibiotic therapy for early Pseudomonas aeruginosa infection in patients with cystic fibrosis (CF) is effective, but the optimal therapeutic regimen and duration for early treatment remains unclear. The EarLy Inhaled Tobramycin for Eradication (ELITE) study was designed to assess the efficacy and safety of two regimens (28 and 56 days) of tobramycin inhalation solution (TIS) 300 mg/5 ml twice daily for the treatment of early onset P aeruginosa infection in patients with CF.
- Publication
Thorax, 2010, Vol 65, Issue 4, p286
- ISSN
1468-3296
- Publication type
Journal Article
- DOI
10.1136/thx.2009.121657